Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rockwell Medical (RMTI)
:RMTI
RMTI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.23 - $5.15
Previous CloseN/A
Volume98.98K
Average Volume (3M)258.68K
Market Cap
$58.17M
Enterprise Value$124.61M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.51
Next Earnings
Mar 13, 2025EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding32,318,806
10 Day Avg. Volume293,875
30 Day Avg. Volume258,682
Standard Deviation0.24
R-Squared0.09
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.60
Price to Cash Flow (P/CF)3.60
P/FCF Ratio4.10
Enterprise Value/Market Cap2.14
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit14.32
Enterprise Value/Ebitda41.21
Forecast
1Y Price Target
$7.00Price Target Upside288.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Rockwell Med News
PremiumCompany Announcements
Rockwell Med Appoints New CFO to Strengthen Leadership
---
Bulls Say, Bears Say
Bulls Say
Market ExpansionRockwell Medical remains committed to expansion in the Western U.S. and sees a potential $100M annual incremental revenue opportunity there based on the fact that historically the company has not had a significant presence in this territory.
Product DevelopmentThe company's introduction of its home dialysis convenience pack underscores RMTI's focus on the rapidly expanding segment of the dialysis market, presenting a significant growth opportunity.
Strategic AgreementsA multi-year product purchase agreement has been inked with a leading provider of dialysis products, expected to mitigate future revenue risks and generate over $10M in net sales in the first year.
Bears Say
Customer Volume DeclineThe largest customer expects future volumes to decline due to supplier diversification.
Price Target AdjustmentThe 12-month price target is being lowered to $7 from the prior $9 per share due to recent developments.
Revenue PressureThe reduction in DaVita's 2025 purchase forecast is a major headwind likely to significantly pressure RMTI's revenue in 2025.
---
Ownership Overview
2.69% Insiders
4.96% Mutual Funds
12.74% Other Institutional Investors
75.69% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RMTI FAQ
What was Rockwell Medical’s price range in the past 12 months?
Rockwell Medical lowest stock price was $1.23 and its highest was $5.15 in the past 12 months.
What is Rockwell Medical’s market cap?
Rockwell Medical’s market cap is $58.17M.
When is Rockwell Medical’s upcoming earnings report date?
Rockwell Medical’s upcoming earnings report date is Mar 13, 2025 which is in 19 days.
How were Rockwell Medical’s earnings last quarter?
Rockwell Medical released its earnings results on Nov 12, 2024. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.04.
Is Rockwell Medical overvalued?
According to Wall Street analysts Rockwell Medical’s price is currently Undervalued.
Does Rockwell Medical pay dividends?
Rockwell Medical does not currently pay dividends.
What is Rockwell Medical’s EPS estimate?
Rockwell Medical’s EPS estimate is <0.01.
How many shares outstanding does Rockwell Medical have?
Rockwell Medical has 32,318,806 shares outstanding.
What happened to Rockwell Medical’s price movement after its last earnings report?
Rockwell Medical reported an EPS of $0.05 in its last earnings report, beating expectations of $0.01. Following the earnings report the stock price went down -39.14%.
Which hedge fund is a major shareholder of Rockwell Medical?
Currently, no hedge funds are holding shares in RMTI
---
Rockwell Med Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (288.89% Upside)
$7.00 (288.89% Upside)
Blogger Sentiment
Bullish
RMTI Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $70.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.7%
Last 30 Days ▼ 9.1%
Last 30 Days ▼ 9.1%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
34.32%
12-Months-Change
Fundamentals
Return on Equity
-6.03%
Trailing 12-Months
Asset Growth
8.51%
Trailing 12-Months
Company Description
Rockwell Medical
Rockwell Medical, Inc. engages in targeting end-stage renal disease and chronic kidney disease. Its dialysis products include hemodialysis concentrates, citrapure, dri-sate, safety data sheets,ancillary products, and renal pure. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
---
RMTI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlights Rockwell Medical's strong financial performance in Q3 2024, with record sales and profitability, along with promising distribution agreements and improved financial guidance. However, there is a concern about the anticipated revenue decline from their largest customer in 2025, which may impact short-term revenue. Despite this, the company expects to maintain profitability and is actively seeking new growth opportunities.Read More>---
RMTI Stock 12 Month Forecast
Average Price Target
$7.00
▲(288.89% Upside)
Technical Analysis
Akebia Therapeutics
―
Aurinia Pharmaceuticals
―
Corbus Pharmaceuticals
―
Kiniksa Pharmaceuticals
―
Best Analysts Covering RMTI
1 Year
1 Year Success Rate
5/12 ratings generated profit
1 Year Average Return
+0.96%
reiterated a buy rating 2 months ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +0.96% per trade.
---